In addition, the EGFR glycosylation pattern in CRC cells is modified by β1,4-N-acetylgalactosaminyltransferase III (B4GALNT3) that has been found overexpressed in advanced CRC stages and has been related with poor prognosis (Table 1). Here, EGFR is linked to colorectal carcinoma.